Advancements in Wearable Tech: Biometric Data Moves Towards Clinical-grade Health Platforms
TL/DR –
Wearables like ŌURA, WHOOP, and Samsung are now being integrated into more clinical-grade health platforms, with a focus on women’s health and biomarker integration. UnitedHealthcare (UHC) announced it will exempt approximately 1,500 rural hospitals from most pre-authorization requirements and accelerate payments to those facilities by up to 50%, a move that will significantly benefit struggling hospitals. Meanwhile, Hone Health has partnered with BodySpec to integrate clinical-grade DEXA body composition scans into its app, marking the entry of DEXA technology into the consumer longevity market.
Wearables Innovate: Rings, Straps, and Watches Join Healthcare Platforms
The wearables industry, traditionally balancing on the edge of healthcare, is shifting towards a more clinical focus. Leading brands like ŌURA, WHOOP, and Samsung are pioneering this transition, integrating women’s health, biomarker data, and enhanced credibility into their wearable tech platforms.
ŌURA, for instance, recently acquired Galen AI, a Stanford-based startup that consolidates fragmented health data. This acquisition aligns with ŌURA’s strategy of providing a comprehensive health record by integrating biomarker data with clinical context. Additionally, ŌURA has partnered with Mira to offer lab-grade hormone measurements within their app, adding more depth to fertility, menopause, and cycle tracking details.
On the other hand, WHOOP secured a massive $575M Series G funding round and landed a significant contract with MIT Lincoln Laboratory to enhance the clinical legitimacy of their data. Meanwhile, Samsung has secured clearance for their Galaxy Watch8’s blood-pressure feature in the U.S.
UnitedHealthcare’s Strategic Move to Support Rural Hospitals
In a recent announcement, UnitedHealthcare (UHC) unveiled plans to exempt around 1,500 rural hospitals from most prior authorization requirements, accelerate payments, and initiate hub-and-spoke partnerships for maternity, diabetes, and post-surgical care. This move, aimed at supporting struggling rural hospitals, was found to be remarkably timely in light of ongoing civil and criminal probes into UHC’s Medicare Advantage billing by the Department of Justice (DOJ).
On the other hand, UHC’s decision also hints at strategic intent. By easing the authorization process at local venues, which typically handle lower-acuity care, UHC avoids impacting high-stakes authorizations at higher-acuity venues like academic medical centers. UHC’s new hub-and-spoke model is also geared towards controlling referral patterns to optimize outcomes and costs.
DEXA Tech in Longevity Product Stack: High Accuracy, Limited Usability
Hone Health, a telehealth provider focusing on longevity, has partnered with BodySpec to incorporate DEXA body composition scans into its platform. Despite DEXA’s best-in-class accuracy and established role in osteoporosis screening, its value for average consumers in the longevity market remains questionable. Utilizing DEXA data for immediate lifestyle changes is possible, but typically limited to marginal adjustments that could also be accomplished with simpler, cheaper tools.
In Hone’s case, the focus on detecting declining bone mineral density or sarcopenia at an early stage when behavior modification can still impact outcomes is a more defensible use case. This approach aligns with the broader trend of preventative healthcare, highlighting how gold-standard technology can offer valuable data, but their effective utilization is what truly determines the product’s value.
—
Read More Health & Wellness News ; US News